Clinical Trials on Prostate Biopsy in Ireland
Total 194 results
-
Cancer Trials IrelandUnknown
-
Cancer Trials IrelandActive, not recruiting
-
Cancer Trials IrelandJanssen, LPCompleted
-
Kira MurphyIrish Research Council; University of Pittsburgh Medical Center; Waterford Instituate...RecruitingExercise | Prostate CancerIreland
-
St. Luke's Hospital, IrelandUnknownProstate CancerIreland, United Kingdom
-
Cancer Trials IrelandCompleted
-
Cancer Trials IrelandCompletedProstate Cancer | Metastatic CancerIreland
-
Guy's and St Thomas' NHS Foundation TrustQueen's University, Belfast; University of Bristol; University of Glasgow; University... and other collaboratorsRecruitingProstate CancerUnited Kingdom
-
Brown UniversityAstraZeneca; The Miriam Hospital; Rhode Island HospitalTerminatedProstate Cancer | Adenocarcinoma of the ProstateUnited States
-
Cancer Trials IrelandCompleted
-
BioProtectRecruitingProstate CancerIreland, Israel, Netherlands, Poland, Portugal
-
Reykjavik UniversityThe Icelandic Research Fund; The Icelandic Cancer SocietyCompleted
-
Galway ClinicUnknownMetabolic Syndrome | Prostate Cancer | Intermittent FastingIreland
-
Kerecis Ltd.CompletedPunch Biopsy Wounds | Healing TimesIceland
-
European Organisation for Research and Treatment...CompletedProstate CancerBelgium, Italy, France, Netherlands, United Kingdom, Poland, Ireland, Spain, Cyprus, Czech Republic, Luxembourg
-
Roger Williams Medical CenterSuspendedTrial of Anti-PSMA Designer T Cells in Advanced Prostate Cancer After Non-Myeloablative ConditioningProstate CancerUnited States
-
University Urological Associates Inc.Unknown
-
Scandinavian Prostate Cancer GroupUnknownProstate CancerFinland, Denmark, Iceland, Norway, Sweden
-
Brown UniversityThe Miriam Hospital; Rhode Island HospitalCompletedProstate CancerUnited States
-
Brown UniversityTerminated
-
SanofiCompletedProstate Cancer MetastaticUnited Kingdom, Austria, Belgium, Czechia, France, Germany, Greece, Iceland, Ireland, Italy, Netherlands, Norway, Spain
-
Roger Williams Medical CenterSuspendedTrial of Anti-PSMA Designer T Cells in Advanced Prostate Cancer After Non-Myeloablative ConditioningMonitor Adverse EventsUnited States
-
Brown UniversityBayer; The Miriam Hospital; Rhode Island Hospital; Clovis Oncology, Inc.Active, not recruitingMetastatic Castration-resistant Prostate CancerUnited States
-
Tampere UniversityCompletedProstate CancerFinland, Ireland, Sweden
-
Cancer Trials IrelandTerminatedMetastatic Cancer | Bone Metastases | Castration-resistant Prostate CancerIreland
-
University of Dublin, Trinity CollegeCompletedObesity | Prostate CancerIreland, United Kingdom
-
Movember FoundationKing's College London; Centre hospitalier de l'Université de Montréal (CHUM); University of California, San Francisco and other collaboratorsActive, not recruitingINTense ExeRcise for surviVAL Among Men With Metastatic Prostate Cancer (INTERVAL - GAP4) (INTERVAL)Metastatic Prostate CancerUnited States, Australia, Netherlands, Canada, United Kingdom, Germany, Ireland
-
UNICANCERBayerRecruitingProstate Cancer MetastaticSpain, France, Ireland, Belgium
-
Rahul AggarwalNovartisCompletedProstate CancerUnited States
-
Brown UniversityKeitner/Family Therapy Research GrantCompletedBreast Cancer | Sexual Dysfunction | Prostate CancerUnited States
-
Merck Sharp & Dohme LLCRecruitingMetastatic Castration-Resistant Prostate CancerUnited States, Austria, Canada, France, Germany, Ireland, Italy, Mexico, Netherlands, New Zealand, Poland, Russian Federation, Sweden, Taiwan, Turkey, Ukraine, United Kingdom, Spain, Finland, Australia, Denmark
-
Progenics Pharmaceuticals, Inc.Active, not recruitingCastration-resistant Prostate Cancer | Metastatic Prostate Cancer | Cancer of the Prostate | Prostatic Neoplasm | Progressive mCRPCUnited States, Canada
-
Institute of Cancer Research, United KingdomUnknownProstate CancerUnited Kingdom
-
AstraZenecaCompletedNon-Metastatic Prostate CancerCzech Republic, Italy, South Africa, United Kingdom, Germany, Poland, Netherlands, Austria, Belgium, Hungary, Israel, Portugal, Mexico, Spain, Australia, Ireland
-
Christopher Sweeney, MBBSSanofi; Hoosier Cancer Research Network; Walther Cancer InstituteTerminatedMetastatic Prostate CancerUnited States, Canada
-
Astellas Pharma IncAstellas Pharma US, Inc.TerminatedProstatic Neoplasms | Hormone-Refractory Prostate CancerUnited States, Ireland, Australia, France, United Kingdom, Belgium, Germany, Netherlands, Poland, Spain
-
Sidekick HealthLandspitali University Hospital; Ljósið Cancer Rehabilitation CenterActive, not recruitingCancer | Colorectal Cancer | Lung Cancer | Prostate CancerIceland
-
National Cancer Institute (NCI)CompletedProstate Adenocarcinoma | Recurrent Prostate Carcinoma | Stage IV Prostate CancerUnited States, Canada
-
Medi-Tate Ltd.CompletedBenign Prostate HyperplasiaUnited States, Canada
-
Brown UniversityThe Miriam HospitalCompletedProstate CancerUnited States
-
Astellas Pharma Global Development, Inc.PfizerCompletedProstate Cancer | Castration-resistant Prostate Cancer | Metastatic Prostate CancerUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Active, not recruitingCastration-Resistant Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8 | Metastatic Prostate AdenocarcinomaUnited States
-
Royal Marsden NHS Foundation TrustUniversity College, London; The Leeds Teaching Hospitals NHS Trust; Belfast Health... and other collaboratorsUnknownProstate Cancer | Metastasis | Toxicity Due to Radiotherapy | Circulating Tumour DNAUnited Kingdom
-
SanofiCompletedProstate Cancer MetastaticAustralia, Austria, Belgium, Bosnia and Herzegovina, Bulgaria, Canada, Croatia, Czech Republic, Denmark, Finland, Hungary, India, Ireland, Italy, Kazakhstan, Luxembourg, Malaysia, Mexico, Philippines, Poland, Portugal, Romania, Serbia, Singapo... and more
-
University of Colorado, DenverBoston Scientific CorporationTerminated
-
DendreonCompletedProstatic Neoplasms | Advanced Prostate CancerUnited States
-
Bristol-Myers SquibbCompleted
-
Memorial Sloan Kettering Cancer CenterUniversity of California, Los Angeles; Ferring Pharmaceuticals; Wayne State University and other collaboratorsCompleted